Delphinus exhibits SoftVue ultrasound imaging system at Premier's Breakthroughs 24 conference
NOVI, Mich.–(BUSINESS WIRE)–Delphinus Medical Technologies announced today that it has been awarded a national group purchasing agreement and Technology Breakthrough Certification from Premier for its SoftVue™ Breast Ultrasound Tomography (UST). Delphinus is now listed as a top supplier to Premier members, who can take advantage of special pricing and terms pre-negotiated by Premier for SoftVue at their discretion. SoftVue was also featured as one of the “latest and greatest” technologies at Breakthrough 24, Premier's annual conference.
Premier awards its Technology Breakthrough designation to innovations that deliver significant benefits in patient safety, clinical outcomes and operational efficiency. Premier rigorously reviews each product submitted for consideration over several months to determine whether it uses innovative technology and provides significant benefits to healthcare organizations and their stakeholders.
“Receiving a Technology Breakthrough Agreement from Premier recognizes SoftVue as a product that represents a significant advancement in advancing high-quality, cost-effective care, and we couldn't agree more,” said Scott White, CEO of Delphinus Medical Technologies. “Through our partnership with Premier, we look forward to continuing to expand our network of customers utilizing our breast imaging technology in combination with mammography as an effective adjunct screening modality for women with dense breasts.”
SoftVue is FDA-cleared for same-day screening with mammograms and, when combined with mammograms, demonstrates advantages in cancer detection in women with dense breasts compared to mammograms alone. SoftVue has been proven to identify up to 25% more cancers in women with dense breasts while reducing unnecessary return visits and short-term follow-ups. Delphinus designed the system to address the fact that breast cancer screening with mammograms alone reduces mortality rates in women with dense breasts by only 13%. SoftVue can be performed at the same appointment as a woman's mammogram, saving patients time and improving diagnostic clinical workflow for breast centers.
Premier is a leading healthcare improvement company that transforms health care by bringing together an alliance of approximately 4,350 hospitals and 300,000 other providers in the U.S. With integrated data and analytics, collaboration, supply chain solutions, consulting and other services, Premier delivers better care and outcomes at lower costs.
The story continues
About Delphinus Medical Technologies, Inc.
Headquartered in Novi, Michigan, Delphinus Medical Technologies, Inc. is a pioneering medical imaging company that developed SoftVue™, the first circular array transducer technology. This patented technology is a radiation-free, compression-free, 3D whole-breast ultrasound system that images the entire breast in a single scan. For more information, visit our website and follow us on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240821672220/en/
contact address
Media Contact:
Sam Choinski
Pazanga Health Communications
[email protected]
(860) 301-5058
